Obesity drug fears investigated (BBC news online, 25 August 2009)
26 Aug 2009
The anti-obesity drug Orlistat has been linked with liver damage. The US Food and Drug Administration are now reviewing the safety of the drug, which works by blocking fat absorption in the body.